Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats

Biological Psychiatry
Perminder S SachdevVanessa Croker

Abstract

Repetitive transcranial magnetic stimulation has been demonstrated in humans as well as in animal models to have an antidepressant effect, but the optimal frequency of stimulation is not known. We examined this question in a rat model of depression. Young male Sprague-Dawley rats were allocated to two placebo (restraint and sham transcranial magnetic stimulation), one active control (imipramine), and four transcranial magnetic stimulation groups at 1, 5, 15 and 25 Hz and 1000 stimuli each. The Porsolt Swim Test was performed on day 1 (experiment 1). In an extension (experiment 2), the treatments were repeated on days 2 through 5, and the Swim Test repeated on days 3, 5, and 7. After one treatment session, all transcranial magnetic stimulation groups had significantly reduced immobility times compared with sham stimulation (p =.000), but the higher frequencies (15 and 25 Hz) did not differ significantly from lower (1 and 5 Hz) frequencies. After three sessions, all transcranial magnetic stimulation groups were different from placebo, and the rapid transcranial magnetic stimulation groups had lower immobility times than the slow transcranial magnetic stimulation groups (p =.035). After five sessions, only 15- and 25-Hz groups wer...Continue Reading

Associated Clinical Trials

References

Jun 1, 1992·Electroencephalography and Clinical Neurophysiology·J D WeissmanK R Davey
Jan 1, 1991·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·D Cohen, B N Cuffin
May 11, 1985·Lancet·A T BarkerI L Freeston
Aug 1, 1994·Brain : a Journal of Neurology·A Pascual-LeoneM Hallett
Oct 15, 1998·Experimental Brain Research·A BerardelliM Manfredi
Apr 10, 1999·Archives of General Psychiatry·M S GeorgeH A Sackeim
Feb 22, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M E KeckM Engelmann
May 10, 2001·The International Journal of Neuropsychopharmacology·Sarah H. LisanbyHarold A. Sackeim

❮ Previous
Next ❯

Citations

Oct 12, 2005·Current Psychiatry Reports·Felipe Fregni, Alvaro Pascual-Leone
Aug 16, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sarah H LisanbyMark S George
May 11, 2006·The Australian and New Zealand Journal of Psychiatry·Philip B Mitchell, Colleen K Loo
Jan 27, 2011·Psychiatry and Clinical Neurosciences·Eiko UeyamaKazuhiro Shinosaki
Jul 12, 2012·Neuromodulation : Journal of the International Neuromodulation Society·Andrew M Vahabzadeh-HaghAlexander Rotenberg
Jun 1, 2011·Asian Journal of Psychiatry·Alvaro Machado DiasMarco Marcolin
May 5, 2009·Experimental Neurology·Frank Padberg, Mark S George
Feb 9, 2012·Journal of Neuroscience Research·Mónica Ambriz-TututiRené Drucker-Colín
Mar 15, 2005·Life Sciences·Kentaro KudoMitsuhiko Yamada
Jun 1, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Nematollah JaafariAntoine Pelissolo
Aug 3, 2011·Neuropharmacology·Sergio MachadoOscar Arias-Carrión
Feb 13, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yuye YangZhengrong Wang
Dec 9, 2015·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Alexander TangJennifer Rodger
Jun 12, 2020·International Journal of Environmental Research and Public Health·Marco CambiaghiFortunato Battaglia
Nov 17, 2009·Behavioural Brain Research·R Canbeyli
Jul 17, 2021·Neural Regeneration Research·Mohammad UzairShahid Bashir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.